PharmTeam

Seth Robey

Seth has always had a passion for scientific discovery, particularly biology and medicine. Seth studied biochemistry at Brandeis University. Now, as a PhD student of Molecular Pharmacology at Columbia University, Seth studies the drugs that help treat cardiac arrhythmias. He's thrilled to be a Motley Fool Contributor, and uncover new and exciting scientific discoveries that could improve our approach to medicine, and provide strong long term investments. Follow @SethRobey on twitter.

PharmTeam’s Activity

Yesterday

NL

Article

PharmTeam published an article 3:00 PM

5 Things Thermo Fisher Scientific Inc.'s Management Wants You to Know

Thermo Fisher Scientific is in a strong position to exploit a growing genomics market. Management knows it -- and they really want you to know it, too.

Mon Oct 13

PharmTeam recommended TMFInnovator's post on a Motley Fool Rule Breakers board. 11:24 PM

Fri Oct 3

CAPS Outperform Pitch

PharmTeam wrote about ESPERION THERAPEUTICS INC (ESPR) . 9:41 AM

ESPR Outperform

The data and market opportunity from ECT-1002 look fantastic. The company is fairly well capitalized and has no debt. Unlike other development stage biotechs, further dilution doesn't seem to be a huge risk because the company is fairly well [more]

Caps Pick

PharmTeam made a pick in CAPS. 9:41 AM

ESPERION THERAPEUTICS INC (ESPR) will Outperform the S&P 500

Fri Sep 26

Caps Pick

PharmTeam made a pick in CAPS. 4:00 PM

Regeneron Pharmaceuticals, Inc. (REGN) will Outperform the S&P 500

Caps Pick

PharmTeam made a pick in CAPS. 3:58 PM

InvenSense (INVN) will Outperform the S&P 500

Wed Sep 24

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 9:32 PM

Mon Sep 22

NL

Article

PharmTeam published an article 11:54 PM

3 Reasons Eli Lilly & Co.'s Stock Could Fall

Management at Eli Lilly & Co. has faced a mountain of challenges in the wake of debilitating patent losses, but the stock has held strong regardless. Here are three reasons that rally may not continue into the future.

Fri Sep 19

Rule Breakers Boards Post

PharmTeam posted to the Rule Breakers boards. 11:12 AM

Thu Sep 4

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 9:06 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 8:12 PM

Tue Sep 2

Stock Advisor Boards Post

PharmTeam replied to the Stock Advisor boards. 10:27 AM

Fri Aug 29

NL

Article

PharmTeam published an article 11:36 AM

3 Reasons Eli Lilly & Co.'s Stock Could Rise

With earnings tumbling over the patent cliff, can diabetes and oncology transform Eli Lilly into a Big Pharma turnaround story?

Thu Aug 21

Stock Advisor Boards Post

PharmTeam posted to the Stock Advisor boards. 9:33 AM

Wed Aug 20

NL

Article

PharmTeam published an article 5:59 PM

5 Things Eli Lilly and Co's Management Wants You to Know

At a critical time for the company, Eli Lilly's management has laid out its plans to return to growth and gave us a good look at what the future holds.

Thu Aug 14

NL

Article

PharmTeam published an article 11:31 AM

3 Building Blocks of a Wearable Technology Revolution

The sky is the limit for wearable medical technology, but it won't be as simple as slapping a smart watch on your wrist.

Wed Aug 13

Caps Pick

PharmTeam made a pick in CAPS. 9:47 AM

Arrowhead Research Corp (ARWR) will Outperform the S&P 500

Mon Aug 4

Rule Breakers Boards Post

PharmTeam posted to the Rule Breakers boards. 12:46 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 10:19 AM

Fri Jul 25

PharmTeam recommended TMFGebinr's post on a Motley Fool Stock Advisor board. 4:29 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 82.41
Player Rank 13202 out of 75065
Score 546.71
Score Change Today +19.89
Accuracy 55.26%
Active Picks 55
Total Picks 76
Best Pick ILMN (+115.96)
Worst Pick CYTK (-76.67)
Average Score per Pick 7.19
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to PharmTeam’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 31
Recs Received 34
People who have rec'd these posts 23
Recs to Posts Ratio (last 30 days) N/A
Threads Started 11
Threads Started Percentage 35.48 %
Most Frequent Board Motley Fool Rule Breakers
Very First Post A SAS: Amazon.com post. (12/1/2013)
Percentage of Posts Rec'd 51.61 %
Show PharmTeam’s 10 Latest Posts